Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 388

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 388
---
 than a price equal to the Series E Conversion Price in effect immediately prior
to such issuance (each, a “Dilutive Issuance”), the Series E Conversion Price shall be reduced to the New Issuance Price;
provided that, if any Dilutive Issuances or other events that would have resulted in an adjustment to the Series E Conversion Price prior
to the Series E Stockholder Approval Date, the Series E Conversion Price shall automatically adjust to such New Issuance Price on the
Series E Stockholder Approval Date.

Bankruptcy Triggering Event Redemption Right. Upon any bankruptcy Series E Triggering Event, the Company shall immediately redeem in cash all amounts due
under the Series E Preferred Stock at a % premium to the greater of (x) the amount of shares of Series E Preferred Stock then outstanding
and (y) the equity value of the shares of Series E Preferred Stock then outstanding, unless the holder waives such right to receive such
payment. The equity value of the Common Stock underlying the Series E Preferred Stock is calculated using the greatest closing sale price
of the Common Stock on any trading day immediately preceding such bankruptcy Series E Triggering Event and the date the Company makes
the entire payment required.

Change of Control Exchange.
Upon a change of control of the Company, each holder may require the Company to exchange the holder’s shares of Series E Preferred
Stock for consideration equal to the Change of Control Election Price (as defined in the Series E Certificate of Designations), to be
satisfied at the Company’s election in either (x) cash or (y) rights convertible into such securities or other assets to which such
holder would have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by such holder upon
consummation of such corporate event.

Company Optional Redemption.
At any time the Company shall have the right to redeem in cash all, but not less than all, the shares of Series E Preferred Stock then
outstanding at a % redemption premium to the greater of (x) the amount of shares being redeemed, and (y) the equity value of the Common
Stock underlying the Series E Preferred Stock. The equity value of the Common Stock underlying the Series E Preferred Stock is calculated
using the greatest closing sale price of the Common Stock on any trading day immediately preceding the date the Company notifies the holders
of the Company’s election to redeem and the date the Company makes the entire payment required.

F-33 Fundamental Transactions. The Series E Certificate of Designations